- Moderna (MRNA.US) COVID-19 vaccine is more than 94% effective
- US records 1 million new Covid-19 cases in a week
- Asia-Pacific countries signed world's biggest trade agreement
European indices finished session higher after Moderna said preliminary trial data showed its coronavirus vaccine was more than 94% effective and does not present any significant safety concerns. Also investors welcomed the news that fifteen countries from Asia-Pacific region including China, Australia, New Zealand, South Korea and Japan signed the Regional Comprehensive Economic Partnership trade deal on Sunday, which brings hopes for an improvement in global trade, which had been hit by U.S.-China tensions. Also, upbeat economic data for Chinese industrial production and Japan Q3 GDP lifted market sentiment. Meanwhile, negotiations between the UK and the EU resumed in Brussels, while the EU summit on November 19th is seen as the final deadline for a draft Brexit deal. However investors remain concerned as some countries in Europe have introduced additional restrictions due to the increase in COVID-19 cases. In Italy, Campania and Tuscany will be placed under the strictest lockdown measures from Sunday. Yesterday Germany economy minister Peter Altmaier said that country must live with “considerable restrictions” against the spread of Covid-19 for at least four to five months. Spain reported 21,371 new cases on Friday, up nearly 2,000 from Thursday and 308 deaths, marking the end of the deadliest week since April. British Prime Minister Boris Johnson is self-isolating after coming into contact with someone who tested positive for Covid-19. During today’s session DAX30 rose 0.5%, CAC40 added 1.7% and FTSE 100 finished 1.66% higher.
US stocks also jumped on vaccine news. Dow Jones gained 1.2% and is trading near its all-time high, S&P500 rose 1.0% and Nasdaq is trading 0.4% higher. Moderna is the second drug maker after Pfizer/BioNTech which announced promising vaccine candidate. Company also said, that its vaccine will stay stable at refrigerated temperatures for 30 days and can be stored for up to six months at negative 4 degrees Fahrenheit/-20°C. By comparison, Pfizer’s vaccine requires a storage temperature of minus 94 degrees Fahrenheit/ -70°C. Stocks that would benefit from the reopening of the economy are the top performers during today's session. United Airlines rose over 6.0%, and Carnival is trading more than 10.0% higher. Bank shares such as JPMorgan Chase and Wells Fargo rose over 2% each and Citigroup climbed nearly 4%. Moderna stock rose over 6.0% while BioNtech stock plunged 15%. Meanwhile the number of coronavirus cases in the United States crossed the 11-million mark of which 133,045 new infections were reported only yesterday. Over the last week, the country reported more than 1 million cases. The number of hospitalizations is also at a record high. Almost 70,000 patients are currently hospitalized due to the virus. Several states have decided to introduce additional restrictions. Michigan authorities introduced remote learning in high schools and colleges for a three-week period, closed movie theaters and casinos, halted exercise classes and stopped indoor dining at restaurants. Washington restricted indoor social gatherings from outside the home, and limited restaurant and bars to outdoor service capacity. On Wednesday Oregon will begin "social freeze" which will last two weeks and Utah enacted a statewide mask mandate, while Ohio is enacting stricter mask mandates for businesses.
US crude futures are trading almost 2.7% higher while the international benchmark Brent contract rose over 2.5% on vaccine news and on prospects that OPEC+ will hold current output curbs. Cartel will hold a ministerial committee meeting tomorrow which could recommend changes to production quotas when all the ministers meet at the end of the month. Elsewhere, gold futures rose nearly 0.25% around $ 1,892 / oz, while silver managed to erase early losses and is trading 0.4 higher% amid weaker US dollar.
![]()
USDCAD – buyers failed to break above the major resistance level at 1.3153 which is additionally strengthened by 20 SMA (blue line) and price pulled back. Should current sentiment prevails, then support at 1.2940 could be at risk. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
USDCAD – buyers failed to break above the major resistance level at 1.3153 which is additionally strengthened by 20 SMA (blue line) and price pulled back. Should current sentiment prevails, then support at 1.2940 could be at risk. Source: xStation5
